Spain Biotech News

The funds will enable the Company to continue the development of TCD-717, its leading product currently in a Phase I clinical trial for the treatment of cancer, as well as expanding its pipeline.

The funds will enable Amadix to advance the development of products that support personalization of treatment for lung and colon cancers.

Biomar Microbial Technologies is interested in finding partners to further pursue their clinical investigations

TCD Pharma ha comenzado en Estados Unidos el ensayo clínico de Fase I de TCD-717 su primer compuesto para el tratamiento de tumores sólidos, tras haber recibido la aprobación de la FDA el pasado mes de septiembre.

Traslational Cancer Drugs Pharma, S.L. (“TCD”) announced today that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors.

Madrid, Spain, February 02, 2010 – Bioalma announced today the release of a novoseek’s API that will allow a customized interaction with the company’s biomedical search engine.

Curaxys is the new company specialized in the production of biosimilars medicines. It is an independent private company, located on the technological park of Cadiz (Spain). The new venture is focuses in the development of new technological platform f

Innoget is announcing today the launching of the new collaborative portal for Open Innovation www.innoget.com . A Web 2.0 linking companies to the scientific community.

BME Global launches the Food & Drink Future Innovation Forum 2009, that will provide a key advantage to every professional who attends, preparing them to overcome the challenges that lie ahead through innovation.